Split-Dose R-CHOP for Older Patients with Treatment Naive DLBCL

被引：0
|
作者：
Kidwell, Adam [1 ]
Furqan, Fateeha [2 ]
Aschenbrenner, Emilie [3 ]
Longo, Walter [4 ]
Devata, Sumana [3 ]
Hamadani, Mehdi [5 ]
Fenske, Timothy S. [2 ]
Shah, Nirav N. [6 ]
机构：
[1] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Milwaukee, WI USA
[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[3] Med Coll Wisconsin, Milwakee, WI USA
[4] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[5] Med Coll Wisconsin Inc, Div Hematol & Oncol, Milwaukee, WI USA
[6] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Brookfield, WI USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203974
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2374 / 2375
页数：2
相关论文
共 50 条
  • [21] Rituximab exposure-response in triweekly R-CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes
    Liu, Shu
    Wang, Zhao
    Chen, Rongxin
    Huang, He
    Wang, Xueding
    Peng, Chen
    Guan, Yanping
    Fang, Xiaojie
    Guan, Shaoxing
    Huang, Hongbing
    Liu, Tao
    Lin, Tongyu
    Huang, Min
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (03): : 680 - 690
  • [22] Retrospective Study of Standard R-CHOP Therapy in Localized DLBCL
    Tomita, Naoto
    Takasaki, Hirotaka
    Miyashita, Kazuho
    Fujisawa, Shin
    Ogusa, Eriko
    Matsuura, Shro
    Kishimoto, Kumiko
    Numata, Ayumi
    Fujita, Atsuko
    Ohshima, Rika
    Kuwabara, Hideyuki
    Hagihara, Maki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Koharazawa, Hideyuki
    Yamazaki, Etsuko
    Fujimaki, Katsumichi
    Taguchi, Jun
    Sakai, Rika
    Ishigatsubo, Yoshiaki
    BLOOD, 2012, 120 (21)
  • [23] Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
    Wilson, Wyndham H.
    Wright, George W.
    Huang, Da Wei
    Hodkinson, Brendan
    Balasubramanian, Sriram
    Fan, Yue
    Vermeulen, Jessica
    Shreeve, Martin
    Staudt, Louis M.
    CANCER CELL, 2021, 39 (12) : 1643 - +
  • [24] R-CHOP in the treatment of DLBCL: Single institution experience from north India.
    Vaid, AK
    Gupta, S
    Doval, DC
    Talwar, V
    Gupta, R
    Sharma, JB
    Chaturvedi, AK
    Prakesh, N
    BLOOD, 2005, 106 (11) : 273B - 273B
  • [25] A non-randomized risk-adjusted comparison of lenalidomide plus R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
    de Jonge, A. Vera
    van Werkhoven, Erik
    Dinmohamed, Avinash G.
    Nijland, Marcel
    Zwinderman, Aeilko H.
    Bossuyt, Patrick M.
    Veldhuis, Martine S.
    Rutten, Emma G. G. M.
    Mous, Rogier
    Vermaat, Joost S. P.
    Sandberg, Yorick
    de Jongh, Eva
    Bilgin, Yavuz M.
    Boersma, Rinske
    Koene, Harry
    Kersten, Marie Jose
    de Jong, Daphne
    Chamuleau, Martine E. D.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [26] R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy
    Gration, B.
    Duran, A.
    Mir, N.
    Yuen, L.
    Warner, M.
    Stanley, K.
    Brady, J.
    Mikhaeel, G.
    Fields, P.
    Wrench, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 172 - 172
  • [27] Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)
    Xiao, Yi
    Wu, Jiaying
    Zhou, Mi
    Shang, Zhen
    Zhu, Ming
    BLOOD, 2023, 142
  • [28] R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy
    Gration, Betty
    Duran, Ana
    Mir, Naheed
    Yuen, Lisa
    Warner, Marcus
    Stanley, Karen
    Brady, Jessica
    Mikhaeel, George
    Fields, Paul A.
    Wrench, David
    BLOOD, 2017, 130
  • [29] Second report of clinical significance of sFas for DLBCL treated with CHOP and new analysis of sFas for DLBCL treated with R-CHOP
    Tsurumi, Hisashi
    Hara, Takeshi
    Kitagawa, Jun-ichi
    Goto, Naoe
    Kanemura, Nobuhiro
    Kasahara, Senji
    Yamada, Toshiki
    Moriwaki, Hisataka
    BLOOD, 2007, 110 (11) : 469A - 469A
  • [30] DLBCL 1L-What to Expect beyond R-CHOP?
    Stegemann, Maike
    Denker, Sophy
    Schmitt, Clemens A.
    CANCERS, 2022, 14 (06)
12345